Literature DB >> 32396611

APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline.

Steve R Makkar1, Darren M Lipnicki1, John D Crawford1, Nicole A Kochan1, Erico Castro-Costa2, Maria Fernanda Lima-Costa2, Breno Satler Diniz3,4, Carol Brayne5, Blossom Stephan6, Fiona Matthews6, Juan J Llibre-Rodriguez7, Jorge J Llibre-Guerra8,9, Adolfo J Valhuerdi-Cepero10, Richard B Lipton11, Mindy J Katz11, Cuiling Wang11, Karen Ritchie12,13, Sophie Carles14,15, Isabelle Carriere12,13, Nikolaos Scarmeas16,17, Mary Yannakoulia18, Mary Kosmidis19, Linda Lam20, Wai Chi Chan20, Ada Fung21, Antonio Guaita22, Roberta Vaccaro22, Annalisa Davin22, Ki Woong Kim23,24, Ji Won Han23, Seung Wan Suh23, Steffi G Riedel-Heller25, Susanne Roehr25, Alexander Pabst25, Mary Ganguli26, Tiffany F Hughes27, Beth Snitz28, Kaarin J Anstey29,30, Nicolas Cherbuin30, Simon Easteal31, Mary N Haan32, Allison E Aiello33,34, Kristina Dang32, Tze Pin Ng35, Qi Gao35, Ma Shwe Zin Nyunt35, Henry Brodaty1,36, Julian N Trollor1,37, Yvonne Leung38, Jessica W Lo1, Perminder Sachdev1,36.   

Abstract

We aimed to examine the relationship between Apolipoprotein E ε4 (APOE*4) carriage on cognitive decline, and whether these associations were moderated by sex, baseline age, ethnicity, and vascular risk factors. Participants were 19,225 individuals aged 54-103 years from 15 longitudinal cohort studies with a mean follow-up duration ranging between 1.2 and 10.7 years. Two-step individual participant data meta-analysis was used to pool results of study-wise analyses predicting memory and general cognitive decline from carriage of one or two APOE*4 alleles, and moderation of these associations by age, sex, vascular risk factors, and ethnicity. Separate pooled estimates were calculated in both men and women who were younger (ie, 62 years) and older (ie, 80 years) at baseline. Results showed that APOE*4 carriage was related to faster general cognitive decline in women, and faster memory decline in men. A stronger dose-dependent effect was observed in older men, with faster general cognitive and memory decline in those carrying two versus one APOE*4 allele. Vascular risk factors were related to an increased effect of APOE*4 on memory decline in younger women, but a weaker effect of APOE*4 on general cognitive decline in older men. The relationship between APOE*4 carriage and memory decline was larger in older-aged Asians than Whites. In sum, APOE*4 is related to cognitive decline in men and women, although these effects are enhanced by age and carriage of two APOE*4 alleles in men, a higher numbers of vascular risk factors during the early stages of late adulthood in women, and Asian ethnicity.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cognitive decline; APOE genotype; Epidemiology; Ethnicity; Sex

Mesh:

Substances:

Year:  2020        PMID: 32396611      PMCID: PMC7518559          DOI: 10.1093/gerona/glaa116

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  46 in total

Review 1.  The mini-mental state examination: a comprehensive review.

Authors:  T N Tombaugh; N J McIntyre
Journal:  J Am Geriatr Soc       Date:  1992-09       Impact factor: 5.562

Review 2.  2003-2013: a decade of body mass index, Alzheimer's disease, and dementia.

Authors:  Tim L Emmerzaal; Amanda J Kiliaan; Deborah R Gustafson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure.

Authors:  Andrew R Bender; Naftali Raz
Journal:  Neuropsychologia       Date:  2012-01-10       Impact factor: 3.139

4.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

Review 5.  Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.

Authors:  Sheila Crean; Alex Ward; Catherine J Mercaldi; Jenna M Collins; Michael N Cook; Nicole L Baker; H Michael Arrighi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-12-01       Impact factor: 2.959

6.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

7.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

8.  Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.

Authors:  Luke W Bonham; Ethan G Geier; Chun C Fan; Josiah K Leong; Lilah Besser; Walter A Kukull; John Kornak; Ole A Andreassen; Gerard D Schellenberg; Howard J Rosen; William P Dillon; Christopher P Hess; Bruce L Miller; Anders M Dale; Rahul S Desikan; Jennifer S Yokoyama
Journal:  Ann Clin Transl Neurol       Date:  2016-08-26       Impact factor: 4.511

9.  Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course.

Authors:  Mark James Rawle; Daniel Davis; Rebecca Bendayan; Andrew Wong; Diana Kuh; Marcus Richards
Journal:  Transl Psychiatry       Date:  2018-01-10       Impact factor: 6.222

10.  Prevalence and change of central obesity among US Asian adults: NHANES 2011-2014.

Authors:  Xuefeng Liu; Yang Chen; Nicole L Boucher; Amy E Rothberg
Journal:  BMC Public Health       Date:  2017-08-25       Impact factor: 3.295

View more
  10 in total

1.  The Impact of Apolipoprotein E Genetic Variability in Health and Life Span.

Authors:  Nalini Raghavachari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-25       Impact factor: 6.053

Review 2.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

3.  Intermuscular fat density as a novel prognostic factor in breast cancer patients treated with adjuvant chemotherapy.

Authors:  Ye Won Jeon; Hyung Soon Park; Yousun Ko; Yu Sub Sung; Byoung Yong Shim; Young Jin Suh; Hyun A Kim
Journal:  Breast Cancer Res Treat       Date:  2021-07-20       Impact factor: 4.872

4.  Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD.

Authors:  Marwan Noel Sabbagh; Evans Pope; Laura Cordes; Jiong Shi; Boris DeCourt
Journal:  Expert Opin Investig Drugs       Date:  2020-12-02       Impact factor: 6.498

5.  Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.

Authors:  Nicolai Franzmeier; M Suárez-Calvet; Lukas Frontzkowski; Annah Moore; Timothy J Hohman; Estrella Morenas-Rodriguez; Brigitte Nuscher; Leslie Shaw; John Q Trojanowski; Martin Dichgans; Gernot Kleinberger; Christian Haass; Michael Ewers
Journal:  Mol Neurodegener       Date:  2020-10-08       Impact factor: 14.195

6.  Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults.

Authors:  Amaryllis A Tsiknia; Emilie Reas; Katherine J Bangen; Erin E Sundermann; Linda McEvoy; James B Brewer; Steven D Edland; Sarah J Banks
Journal:  Brain Commun       Date:  2022-02-18

7.  Incidence and Cognitive Decline of Alzheimer's Disease and Other Dementia by Apolipoprotein ε4 Allele Presence: A Community-Based Cohort Study in Korean Elderly.

Authors:  So Young Yoo; Alexander Han; Soowon Park; Jun-Young Lee
Journal:  Psychiatry Investig       Date:  2022-03-03       Impact factor: 2.505

Review 8.  Genes and Longevity of Lifespan.

Authors:  May Nasser Bin-Jumah; Muhammad Shahid Nadeem; Sadaf Jamal Gilani; Fahad A Al-Abbasi; Inam Ullah; Sami I Alzarea; Mohammed M Ghoneim; Sultan Alshehri; Aziz Uddin; Bibi Nazia Murtaza; Imran Kazmi
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

9.  Network Modeling Sex Differences in Brain Integrity and Metabolic Health.

Authors:  Janelle T Foret; Maria Dekhtyar; James H Cole; Drew D Gourley; Marie Caillaud; Hirofumi Tanaka; Andreana P Haley
Journal:  Front Aging Neurosci       Date:  2021-06-29       Impact factor: 5.750

10.  APOE alleles' association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL).

Authors:  Einat Granot-Hershkovitz; Wassim Tarraf; Nuzulul Kurniansyah; Martha Daviglus; Carmen R Isasi; Robert Kaplan; Melissa Lamar; Krista M Perreira; Sylvia Wassertheil-Smoller; Ariana Stickel; Bharat Thyagarajan; Donglin Zeng; Myriam Fornage; Charles S DeCarli; Hector M González; Tamar Sofer
Journal:  Alzheimers Dement       Date:  2020-11-06       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.